Intelligence Platform
Patents
Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10766902
Wee-1 inhibiting pyrazolopyrimidinone compounds
granted patentUS 10765600
Adapter for use in a planetary mixer
granted patentUS 10759863
Modulation of Ξ³Ξ΄ T cells
granted patentUS 10738093
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global ge
granted patentUS 10717720
Modified compound of andrographolide
granted patentUS 10716782
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted patentUS 10717765
Compositions and methods for treating autoimmune and inflammatory disorders
granted patentUS 10716808
Methods and compositions to modulate hair growth
granted patentUS 10703735
4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the tr
granted patentUS 10696654
Therapeutic compounds
granted patentUS 10689397
ULK1 inhibitors and methods using same
granted patentUS 10689347
Substituted heterocyclyl derivatives as CDK inhibitors
granted patentUS 10683283
Substituted ureas and methods of making and using same
granted patentUS 10682416
Epicardial-derived paracrine factors for repairing cardiac tissue
granted patentUS 10676474
1,6-naphthyridine derivatives as CDK4/6 inhibitor
granted patentUS 10668055
Cancer treatment using combinations of ERK and RAF inhibitors
granted patentUS 10669311
Targeted delivery system and methods of use therefor
granted patentUS 10653172
Natural stilbenes as sweeteners or sweetener enhancer
granted patentUS 10653173
Method for masking unpleasant taste
granted patentUS 10653797
Compounds and compositions for targeting brain injuries and methods of use thereof
granted patentUS 10647689
Apelin receptor agonists and methods of use thereof
granted patentUS 10647710
Thiazole derivative and applications thereof
granted patentUS 10639348
Peptides with anti-cancer activity
granted patentUS 10640517
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted